SANOFI-AVENTIS (EPA:SAN) Sanofi partnering with leading academic cooperative groups to study amcenestrant in the adjuvant setting for patients with estrogen receptor positive breast cancer
Transparency directive : regulatory news
04/06/2021 07:00
SANOFI-AVENTIS's latest news
17/04/2024 07:00
12/04/2024 20:05
22/03/2024 07:30
15/03/2024 20:04
24/02/2024 15:51
23/02/2024 18:45
23/02/2024 07:00
22/02/2024 19:02
20/02/2024 23:40
15/02/2024 14:00
Other stories
19/04/2024 08:05
18/04/2024 21:44
19/04/2024 06:30
19/04/2024 00:07
19/04/2024 00:08
19/04/2024 06:33
18/04/2024 16:57
19/04/2024 00:20
18/04/2024 07:03
18/04/2024 23:21
18/04/2024 16:01
19/04/2024 01:40
19/04/2024 08:37
18/04/2024 21:25
19/04/2024 01:11
18/04/2024 21:21
19/04/2024 06:53
19/04/2024 09:20
18/04/2024 19:44
18/04/2024 17:33
18/04/2024 12:45
18/04/2024 17:53
19/04/2024 09:09
19/04/2024 01:26
19/04/2024 01:46
18/04/2024 22:41
19/04/2024 06:51
19/04/2024 08:30
19/04/2024 08:30
19/04/2024 05:03
18/04/2024 11:33
18/04/2024 17:58
18/04/2024 11:30
17/04/2024 09:30
19/04/2024 03:30
18/04/2024 08:00
19/04/2024 07:05
18/04/2024 17:22